Global small animal imaging reagents Market size- Industry Trends & Forecast Report 2027.
The global small animal imaging reagents market is projected to reach USD 3.4 billion by 2027, growing at a CAGR of 10.7% during 2021-2027 (forecast period). The small animal imaging reagents market is likely to grow in the forecast timeframe due to the advanced technology in the field of molecular imaging, rising market demand for non-invasive small animal imaging techniques, and a significantly growing number of public-private initiatives to support preclinical researches ar. In addition, rising public-private investments to support radioisotope production, the rising number of translational research activities, and an evolving regulatory scenario are the major growth factors of the market.
Global Small Animal Imaging Reagents Market Overview:
Small-animal imaging is a technique that allows the scientist to test-drive the therapies and compounds. It usually provides a way to monitor disease progression and mechanisms for tracking various disease phenomena over time. The use of small animal models in basic and preclinical sciences constitutes for institutions is an integral part of testing new pharmaceutical agents before commercial translation to clinical practice. The major applications of the small animal imaging market include the use of extensively for various purposes. The small animal imaging system and reagents have extensive applications in the oncology area and the upsurge in cases of cancers across the globe.
Small Animal Imaging Reagents Market Forecast and Trends
Growing usage of Multimodal Imaging Instruments
Multimodality imaging has been considered vital to involve the incorporation of two or more imaging modalities. Since molecular imaging has its vital roots in molecular biology and imaging technology, it has also been exploited in biomedical research that involves the use of small animals to visualize and track several molecular processes in vivo. In the past years, significant progress has been seen in the development of molecular imaging, especially in multimodality small-animal instrumentation. In addition, multimodality imaging, a combination of imaging modalities may provide a better solution to overcome the limitations of the independent techniques.
Rise In the Pharmaceutical Industry and R&D Expenditures
The pharmaceutical market across the globe is expected to grow in the upcoming years despite the recent slowdown in key markets. The aging and growing population, rising income levels, and emerging medical conditions and along with the emergence of new diseases are the major driver's factors. These would be directly benefiting the small animal imaging market growth. For instance, In 2019, the pharmaceutical industry spent 186 billion U.S. dollars on research and development, which is an increase of over five billion compared to the previous year.
Government Stringent Regulations
The federal regulation is largely intended to ensure that health care patients receive safe, high-quality care. This leads to the formulation of stringent regulations across the globe in the healthcare and research industry. Patients also are affected through less time with their caregivers, unnecessary hurdles to receiving care, and a growing regulatory morass that fuels higher health care costs. Regulation is the best way to make sure that healthcare professionals are safe to practice and remain safe to practice throughout their career, hence this factor may act as the major restraint for the market.
Impact of COVID-19 in industry
The global economy and humanity have been pushed into a crisis due to the COVID-19 pandemic. Due to the high infection rate and adverse impact on public health systems, various governments have enforced nationwide lockdowns significantly impacting manufacturing supply chains, trade, and related services. Players are currently considering digital solutions that would enable them to serve the community and provide new opportunities to do business. The production, manufacturing, supply chain, and other operations, have slowed down globally aimed to limit the spread of coronavirus,
The global impact of the coronavirus disease 2019 (COVID-19) is likely only beginning and would significantly affect the small animal imaging reagents market in 2020. The outbreak of COVID-19 has brought with it travel bans and quarantines; massive slowing of the supply chain; uncertainty in the stock market; falling business confidence, and growing panic among the population. Despite the growing uncertainty and panic, technology suppliers must continue to focus on their long-term investments, maintain engagement with partners and prospects, and look to specific markets for stability.
Small Animal Imaging Reagents Market: By Modality
Based on the Modality, the small animal imaging reagents market is segmented into Optical Imaging, PET, SPECT, CT, MRI, ultrasound, Photoacoustic Imaging, Magnetic Particle Imaging. The optical imaging segment followed by ultrasound and MRI are likely to dominate in the small animal imaging reagents market as the engineering of optical agents with distinct optical contrast characteristics and the ability to target specific biological processes and biomarkers, photonic small animal imaging is seeing a revolution of technologies and applications in recent year.
Source: BlueWeave Consulting
Small Animal Imaging Reagents Market: Regional Insight
North America region is likely to dominate in the small animal imaging reagents market, followed by the Asia Pacific, and others. The developing countries like the US and Canada have major opportunities for industrial production, retail sales, and fixed-asset investment for the small animal imaging reagents. Several other economies such as Indonesia, the Philippines, and Singapore in the Asia Pacific region are also forecast to grow at modest rates. The company's productivity is directly proportional to the productivity of workers. Hence, businesses in these regions are commonly embracing different instruments to help workers increase their productivity.
· Aspect Imaging recently had launched an M2 3D MR-based histology system for in-vivo and ex-vivo toxicological imaging. The M2 3D MR-based histology system is a compact, multimodal, and high-resolution MRI instrument for high-throughput in-vivo and ex-vivo imaging of preclinical subjects. The M2 also provides a wide range of benefits of MRI including high-resolution 3D images of internal, anatomical morphology, and quantitative information regarding disease progression and regression.
· Technical innovations such as high-resolution MRI with other modalities and a rising number of pharmaceutical & research organizations are among key trends stimulating market growth.
The small animal imaging reagents market is fragmented owing to the presence of several companies that provides varied small animal imaging reagents products. However, the companies that hold the majority share of the small animal imaging reagents market are erkinElmer Inc. Bruker Corporation, FUJIFILM Holdings Corporation, Mediso Ltd., MILabs B.V., MR Solutions Ltd. Aspect Imaging, LI-COR Biosciences, Thermo Fisher Scientific, Perkinelmer, Bruker, Fujifilm Holdings, Trifoil, Miltenyi Biotec, Mediso, Aspect Imaging, Li-Cor Biosciences, Trifoil Imaging, and other prominent players.
In the small animal imaging reagents market, prominent market participants compete based on price and product quality. Small and medium-sized market players are expected to show considerable improvements in the foreseeable future, given the moderate level of capital expenditure needed to set up a business. The large-sized companies, however, are likely to aim for global expansion, in a bid to gain a more considerable brand reputation.
Scope of the Report
Historical data – 2016-2019
Base Year – 2020
Forecast – 2021 – 2027
Revenue in USD Million
U.S, Canada, Germany, UK, France, Italy, Spain, Russia, Brazil, Japan, South Korea, China, UAE, South Africa, UAE, Turkey, India, Rest of APAC, Mexico, Argentina, Rest of Latin America, Saudi Arabia, Rest of MEA, Rest of Europe, GCC
By Modality, By Reagents and By Region
ErkinElmer Inc. Bruker Corporation ,FUJIFILM Holdings Corporation , Mediso Ltd. , MILabs B.V. , MR Solutions Ltd. Aspect Imaging , LI-COR Biosciences, thermo Fisher Scientific, Perkinelmer, Bruker, Fujifilm Holdings, Trifoil, Miltenyi Biotec, Mediso, Aspect Imaging, Li-Cor Biosciences, Trifoil Imaging and others.
Scope of the Report
Ø Optical Imaging
Ø Photoacoustic Imaging
Ø Magnetic Particle Imaging
Ø Optical Imaging Reagents
Ø Contrast Agents
Ø PET Tracers
Ø SPECT Probes
Ø North America
Ø Asia Pacific
Ø Middle East and Africa